Secukinumab is effective in the treatment of recalcitrant palmoplantar psoriasis and palmoplantar pustular psoriasis in a daily practice setting

J Am Acad Dermatol. 2022 Sep;87(3):705-709. doi: 10.1016/j.jaad.2022.05.047. Epub 2022 May 28.
No abstract available

Keywords: daily practice setting; palmoplantar psoriasis; palmoplantar pustular psoriasis; secukinumab.

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Humans
  • Psoriasis* / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • secukinumab